Estimates Revisions Valneva SE Pref. Euronext Paris
Stocks
VLAP
FR0011472943
Biotechnology & Medical Research
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 05-13 | Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-13 | Valneva SE, Q1 2026 Earnings Call, May 13, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- VLA Stock
- VLAP Stock
- Consensus Valneva SE Pref.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
